Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-25 @ 3:08 PM
NCT ID:
NCT02476968
Pre Assignment Details:
181 patients enrolled and assigned to olaparib: 145 with breast cancer susceptibility gene mutation (BRCAm) status (87 with germline mutations \[gBRCAm\], 55 with somatic mutations \[sBRCAm\] and 3 with undetermined BRCAm status), 33 with BRCA-independent homologous recombination repair mutation (HRRm\^) status, and 3 enrolled in error (unassigned).
Recruitment Details:
This study was conducted in 8 countries in patients with platinum sensitive relapsed high grade epithelial ovarian (including fallopian tube or primary peritoneal) cancer, who were in complete or partial response to platinum-based chemotherapy.
Study:
NCT02476968
Study Brief:
Results Section:
NCT02476968